CorVista Health Launches Clinical Decision Support and Commercial Availability of PCWP Algorithm, Taking the CorVista® Platform from Testing to Guideline-Driven Action

BETHESDA, Md.–(BUSINESS WIRE)–CorVista Health today announced the launch of CorVista Clinical Decision Support (CDS) and the U.S. commercial availability of the CorVista® System Pulmonary Capillary Wedge Pressure (PCWP) Add-On. The two milestones mark the next step for the CorVista platform: moving beyond noninvasive test results to clear, guideline-recommended next steps for patients.A key barrier to bringing advanced cardiopulmonary diagnostics into primary care is clinical fit. Physicians n

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.